Andrew Huberman outlined an ambitious vision of the future of personal health, in which GLP-1 drugs could drastically reduce obesity and peptides would become part of everyday consumption. But along with optimism, he issued a clear warning: the grey market is already moving faster than regulation, and overstimulating the body could have serious costs. *** Huberman stated that, in theory, GLP-1 could eradicate obesity and estimated that more than…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Andrew Huberman outlined an ambitious vision of the future of personal health, in which GLP-1 drugs could drastically reduce obesity and peptides would become part of everyday consumption. But along with optimism, he issued a clear warning: the grey market is already moving faster than regulation, and overstimulating the body could have serious costs. *** Huberman stated that, in theory, GLP-1 could eradicate obesity and estimated that more than…